Central nervous system specialist Neuraxpharm has capitalized on its collaboration with Israel’s Panaxia Labs – a developer and manufacturer of advanced medical cannabis-based products – to become the first firms in Europe to sell medical cannabis extracts for vaporization in Germany, under the joint brand Naxiva-Panaxol.
“With the first sales of medical cannabis extracts which may be used for vaporization in Germany, we have reached another milestone in our successful partnership with Panaxia,” said Jörg-Thomas Dierks, CEO of Neuraxpharm
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?